摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-甲苯磺酰基吡咯烷酮 | 10019-95-1

中文名称
N-甲苯磺酰基吡咯烷酮
中文别名
——
英文名称
N-tosylpyrrolidinone
英文别名
1-tosylpyrrolidin-2-one;N-tosylpyrrolidin-2-one;N-tosylpyrrolidone;1-(p-Toluenesulfonyl)-2-pyrrolidinone;1-(4-methylphenyl)sulfonylpyrrolidin-2-one
N-甲苯磺酰基吡咯烷酮化学式
CAS
10019-95-1
化学式
C11H13NO3S
mdl
MFCD00010421
分子量
239.295
InChiKey
AAXCXJDQWSSCHL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    144-145 °C(Solv: ethanol (64-17-5))
  • 沸点:
    382.8±35.0 °C(Predicted)
  • 密度:
    1.2835 (rough estimate)
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    62.8
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2933790090
  • 储存条件:
    存放于阴凉干燥处。

SDS

SDS:798be873bba46a51f2b35ee1c246127b
查看
Name: N-Tosylpyrrolidone Material Safety Data Sheet
Synonym: 1-(P-Toluenesulfonyl)-2-Pyrrolidinon
CAS: 10019-95-1
Section 1 - Chemical Product MSDS Name:N-Tosylpyrrolidone Material Safety Data Sheet
Synonym:1-(P-Toluenesulfonyl)-2-Pyrrolidinon

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
10019-95-1 N-Tosylpyrrolidone ca 100 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 10019-95-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: light yellow to tan
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 144-146C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H13NO3S
Molecular Weight: 239.29

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 10019-95-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-Tosylpyrrolidone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 10019-95-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 10019-95-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 10019-95-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    N-甲苯磺酰基吡咯烷酮 在 3,6‐di‐tert‐butyl‐9‐mesityl‐10‐phenylacridin‐10‐ium tetrafluoroborate 、 N,N-二异丙基乙胺 作用下, 以 乙腈 为溶剂, 反应 48.0h, 以99%的产率得到2-吡咯烷酮
    参考文献:
    名称:
    吖啶自由基光还原剂的发现和表征
    摘要:
    光致电子转移 (PET) 是一种现象,化学物质对光的吸收为电子转移反应提供能量驱动力1,2,3,4. 这种机制与许多化学领域相关,包括自然和人工光合作用、光伏和光敏材料的研究。近年来,光氧化还原催化领域的研究使 PET 能够用于催化生成中性和带电的有机自由基物种。这些技术使以前无法实现的化学转化成为可能,并已广泛用于学术和工业环境。这种反应通常由吸收可见光的有机分子或钌、铱、铬或铜的过渡金属配合物催化5,6. 尽管各种闭壳有机分子已被证明在光氧化还原反应中充当有效的电子转移催化剂,但涉及中性有机自由基作为激发态供体或受体的 PET 反应的报道有限。这并不奇怪,因为中性有机自由基的双重激发态的寿命通常比已知的过渡金属光氧化还原催化剂的单重激发态寿命短几个数量级7,8,9,10,11。在这里,我们记录了最大激发态氧化电位为 -3.36 伏的中性吖啶自由基与饱和甘汞电极的发现、表征和反应性,后者
    DOI:
    10.1038/s41586-020-2131-1
  • 作为产物:
    描述:
    N-(but-3-yn-1-yl)-4-methylbenzenesulfonamide 在 甲烷磺酸tris(p-trifluoromethylphenyl)phosphine gold bis(trifluoromethanesulfonyl)imidate间氯过氧苯甲酸 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 5.0h, 以47%的产率得到N-甲苯磺酰基吡咯烷酮
    参考文献:
    名称:
    金催化手性同炔丙基酰胺的氧化环化:对映体富集的γ-内酰胺的合成
    摘要:
    已开发了金催化的高炔丙基酰胺的串联环异构化/氧化反应,通过结合手性叔丁基亚磺酰亚胺化学和金催化作用,可以方便地获得具有出色ee的合成有用的手性γ-内酰胺。这种方法的实用性也已在生物活性化合物S -MPP和天然产物(-)-古吉甘碱的合成中得到证明。使用容易获得的起始原料,简单的步骤以及温和的反应条件是该方法的其他重要特征。
    DOI:
    10.1021/jo400127x
点击查看最新优质反应信息

文献信息

  • Transamidation for the Synthesis of Primary Amides at Room Temperature
    作者:Jiajia Chen、Yuanzhi Xia、Sunwoo Lee
    DOI:10.1021/acs.orglett.0c00958
    日期:2020.5.1
    Various primary amides have been synthesized using the transamidation of various tertiary amides under metal-free and mild reaction conditions. When (NH4)2CO3 reacts with a tertiary amide bearing an N-electron-withdrawing substituent, such as sulfonyl and diacyl, in DMSO at 25 °C, the desired primary amide product is formed in good yield with good funcctional group tolerance. In addition, N-tosylated
    在无金属和温和的反应条件下,使用各种叔酰胺进行转酰胺作用,可以合成出各种伯酰胺。当(NH4)2CO3在25°C的DMSO中与带有N吸电子取代基的叔酰胺(如磺酰基和二酰基)反应时,可以形成具有良好官能团耐受性的高收率的所需伯酰胺产物。另外,N-甲苯磺酸化的内酰胺衍生物通过开环反应提供了它们相应的N-甲苯磺酰胺基烷基酰胺产物。
  • One-Pot Double-Annulation Strategy for the Synthesis of Unusual Fused Bis-Heterocycles
    作者:Shukree Abdul-Rashed、Georgios Alachouzos、William W. Brennessel、Alison J. Frontier
    DOI:10.1021/acs.orglett.0c01351
    日期:2020.6.5
    A novel metal-free double-annulation cascade for the construction of unusual fused heterocyclic systems is described. This simple protocol enables the sequential assembly of two rings in one pot from two simple precursors. Acidic conditions promote the condensation and the intramolecular alkynyl Prins reaction of an enyne or arenyne alcohol with a cyclic hemiaminal to form a five-, six-, or seven-membered
    描述了一种新颖的无金属双环环反应级联,用于构造不寻常的稠合杂环系统。这个简单的协议使得两个简单的前体可以在一个罐中顺序组装两个环。酸性条件促进烯炔或芳烃与环状半缩醛的缩合和分子内炔基普林斯反应,形成五元,六元或七元的氧杂环,然后形成七元或八元的氮杂环。在这种转变中,在一个合成操作中形成三个新的键(一个C–O,一个C–C和一个C–N)会迅速产生化学复杂性。该策略是模块化的,相对通用,可访问一系列独特的稠合双环支架。
  • Ruthenium-Pincer-Catalyzed Hydrogenation of Lactams to Amino Alcohols
    作者:Jiangbo Chen、Jiaquan Wang、Tao Tu
    DOI:10.1002/asia.201800759
    日期:2018.9.4
    available ruthenium pincer complex (Ru‐MACHO‐BH) as a catalyst, the challenging direct hydrogenation of lactams and analogues has been successfully accomplished to deliver corresponding value‐added amino alcohols in good‐to‐excellent yields under mild reaction conditions. Remarkably, in addition to N‐protected lactams, unprotected ones could also be readily reduced in the presence of a catalytic amount
    通过使用市售的钌夹钳络合物(Ru‐MACHO‐BH)作为催化剂,成功完成了具有挑战性的内酰胺和类似物的直接氢化反应,以在温和的反应条件下以良好或优异的产率提供相应的增值氨基醇。值得注意的是,除了N保护的内酰胺外,在催化量的弱碱存在下甚至在中性反应条件下,未保护的内酰胺也可以轻松还原,这进一步突出了广泛的底物范围和操作效率。
  • Robust Synthesis of <i>N</i>-Sulfonylazetidine Building Blocks via Ring Contraction of α-Bromo <i>N</i>-Sulfonylpyrrolidinones
    作者:Nicolas Kern、Anne-Sophie Felten、Jean-Marc Weibel、Patrick Pale、Aurélien Blanc
    DOI:10.1021/ol5029496
    日期:2014.12.5
    A simple and robust one-pot nucleophilic addition–ring contraction of α-bromo N-sulfonylpyrrolidinones has been achieved toward α-carbonylated N-sulfonylazetidines. In the presence of potassium carbonate, various nucleophiles, such as alcohols, phenols or anilines, have been efficiently incorporated into the azetidine derivatives. Moreover, the α-bromopyrrolidinone precursors could be selectively obtained
    对α-羰基化的N-磺酰基氮杂环丁烷,已经实现了一种简单而健壮的α-溴N-磺酰基吡咯烷酮单罐亲核加成环收缩。在碳酸钾的存在下,各种亲核试剂,例如醇,酚或苯胺,已被有效地掺入氮杂环丁烷衍生物中。而且,可以通过廉价和容易获得的N-磺酰基-2-吡咯烷酮衍生物的单溴化,以高收率选择性地获得α-溴吡咯烷酮前体。
  • Selective C–H Olefination of Indolines (C5) and Tetrahydroquinolines (C6) by Pd/S,O-Ligand Catalysis
    作者:Wen-Liang Jia、Nick Westerveld、Kit Ming Wong、Thomas Morsch、Matthijs Hakkennes、Kananat Naksomboon、M. Ángeles Fernández-Ibáñez
    DOI:10.1021/acs.orglett.9b03505
    日期:2019.12.6
    highly selective C-H olefination of directing-group-free indolines (C5) and tetrahydroquinolines (C6) by Pd/S,O-ligand catalysis. In the presence of the S,O-ligand, a wide range of challenging indolines, tetrahydroquinolines, and olefins was efficiently olefinated under mild reaction conditions. The synthetic potential of this methodology was demonstrated by the efficient olefination of several indoline-based
    在本文中,我们报告了通过Pd / S,O-配体催化的无方向性二氢吲哚(C5)和四氢喹啉(C6)的高选择性CH烯化反应。在S,O-配体的存在下,在温和的反应条件下,有效地将各种挑战性的二氢吲哚,四氢喹啉和烯烃进行了烯化。这种方法的合成潜力已通过几种基于二氢吲哚的天然产物的有效烯化得到证明。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐